Univariate and multivariate analysis of prognostic factors in the surgical treatment of hepatocellular carcinoma in cirrhotic patients. 2006

Giovanni Ramacciato, and Paolo Mercantini, and Giuseppe R Nigri, and Matteo Ravaioli, and Nicola Cautero, and Fabrizio Di Benedetto, and Michele Masetti, and Gian Luca Grazi, and Vincenzo Ziparo, and Giorgio Ercolani, and Antonio Daniele Pinna
Department of General Surgery, Hepato-biliary-pancreatic Unit, University of Rome "La Sapienza" II Faculty of Medicine, Sant'Andrea Hospital, Rome, Italy. giovanni.ramacciato@uniroma1.it

OBJECTIVE Evaluation of the short- and long-term outcome of liver resections for HCC in cirrhotic patients. METHODS A retrospective analysis was performed on 106 consecutive cirrhotic patients with HCC resected between June 1974 and September 2002. Univariate and multivariate analyses were performed on several clinicopathological variables to analyze factors affecting the long-term outcome and intrahepatic recurrence. RESULTS Overall mortality and morbidity were 10.7% and 26% respectively. These rates significantly decreased in the last years: from 1997 to 2002 no hospital mortality has been recorded. After a median follow-up of 19 months (interquartile range: 10-36), tumor recurrence appeared in 25 patients (23.5%). The 1-, 3-, and 5-year overall survival rates were 86.6%, 70.3%, and 60.6%, respectively. The 1-, 3-, and 5-year disease-free survival rates were 86.3%, 58.1%, and 40.7%. Univariate analysis showed that viral etiology of cirrhosis (p=0.03), presence of multiple nodules (p=0.02) and vascular invasion (p=0.05) are related to a worse long-term survival. Multivariate analysis showed that only the viral etiology of cirrhosis and the presence of multiple nodules were significant independent prognostic factors. CONCLUSIONS Results after hepatic resection for HCC in cirrhotic patients can be improved by using a limited surgical approach. The viral etiology of cirrhosis, the presence of multiple nodules and vascular invasion negatively affected recurrence rate and long-term survival.

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D006498 Hepatectomy Excision of all or part of the liver. (Dorland, 28th ed) Hepatectomies
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Giovanni Ramacciato, and Paolo Mercantini, and Giuseppe R Nigri, and Matteo Ravaioli, and Nicola Cautero, and Fabrizio Di Benedetto, and Michele Masetti, and Gian Luca Grazi, and Vincenzo Ziparo, and Giorgio Ercolani, and Antonio Daniele Pinna
April 2003, World journal of surgery,
Giovanni Ramacciato, and Paolo Mercantini, and Giuseppe R Nigri, and Matteo Ravaioli, and Nicola Cautero, and Fabrizio Di Benedetto, and Michele Masetti, and Gian Luca Grazi, and Vincenzo Ziparo, and Giorgio Ercolani, and Antonio Daniele Pinna
December 2002, Journal of surgical oncology,
Giovanni Ramacciato, and Paolo Mercantini, and Giuseppe R Nigri, and Matteo Ravaioli, and Nicola Cautero, and Fabrizio Di Benedetto, and Michele Masetti, and Gian Luca Grazi, and Vincenzo Ziparo, and Giorgio Ercolani, and Antonio Daniele Pinna
November 2010, The American surgeon,
Giovanni Ramacciato, and Paolo Mercantini, and Giuseppe R Nigri, and Matteo Ravaioli, and Nicola Cautero, and Fabrizio Di Benedetto, and Michele Masetti, and Gian Luca Grazi, and Vincenzo Ziparo, and Giorgio Ercolani, and Antonio Daniele Pinna
March 1990, Cancer,
Giovanni Ramacciato, and Paolo Mercantini, and Giuseppe R Nigri, and Matteo Ravaioli, and Nicola Cautero, and Fabrizio Di Benedetto, and Michele Masetti, and Gian Luca Grazi, and Vincenzo Ziparo, and Giorgio Ercolani, and Antonio Daniele Pinna
February 1986, Journal of surgical oncology,
Giovanni Ramacciato, and Paolo Mercantini, and Giuseppe R Nigri, and Matteo Ravaioli, and Nicola Cautero, and Fabrizio Di Benedetto, and Michele Masetti, and Gian Luca Grazi, and Vincenzo Ziparo, and Giorgio Ercolani, and Antonio Daniele Pinna
April 2001, The American journal of gastroenterology,
Giovanni Ramacciato, and Paolo Mercantini, and Giuseppe R Nigri, and Matteo Ravaioli, and Nicola Cautero, and Fabrizio Di Benedetto, and Michele Masetti, and Gian Luca Grazi, and Vincenzo Ziparo, and Giorgio Ercolani, and Antonio Daniele Pinna
November 1995, Bulletin du cancer,
Giovanni Ramacciato, and Paolo Mercantini, and Giuseppe R Nigri, and Matteo Ravaioli, and Nicola Cautero, and Fabrizio Di Benedetto, and Michele Masetti, and Gian Luca Grazi, and Vincenzo Ziparo, and Giorgio Ercolani, and Antonio Daniele Pinna
March 2007, ANZ journal of surgery,
Giovanni Ramacciato, and Paolo Mercantini, and Giuseppe R Nigri, and Matteo Ravaioli, and Nicola Cautero, and Fabrizio Di Benedetto, and Michele Masetti, and Gian Luca Grazi, and Vincenzo Ziparo, and Giorgio Ercolani, and Antonio Daniele Pinna
March 1989, Cancer,
Giovanni Ramacciato, and Paolo Mercantini, and Giuseppe R Nigri, and Matteo Ravaioli, and Nicola Cautero, and Fabrizio Di Benedetto, and Michele Masetti, and Gian Luca Grazi, and Vincenzo Ziparo, and Giorgio Ercolani, and Antonio Daniele Pinna
January 2004, Hepato-gastroenterology,
Copied contents to your clipboard!